Search

For 2018, 30 EU/EEA countries reported 7 643 confirmed shigellosis cases.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 September 2022 and includes updates on cholera, polio, COVID-19, monkeypox, West Nile virus, and Ebola virus disease.

In 2019, 314 confirmed brucellosis cases were reported in the EU/EEA. The notification rate in the EU/EEA was 0.06 cases per 100 000 population. The highest rates were reported in Greece, Portugal and Slovenia. The EU/EEA notification rate decreased in the period 2015 to 2019.

In 2020, 134 confirmed brucellosis cases were reported in the EU/EEA. The notification rate in the EU/EEA was 0.03 cases per 100 000 population. The highest rates were reported in Greece, Portugal, and Sweden. The notification rate decreased in the period 2016 to 2020 in the EU/EEA

For 2020, 28 EU/EEA countries reported 4 824 confirmed cases of Shiga toxin -producing Escherichia coli (STEC) infection. The overall notification rate was 1.6 cases per 100 000 population. The highest notification rates were reported in Ireland, Malta, Denmark, and Norway. The EU/EEA notification rate decreased notably in 2020 compared with 2016-2019 due to the COVID-19 pandemic.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 September 2022 and includes updates on COVID-19, monkeypox, West Nile virus infection, Ebola, Vibrio growth, dengue, and MERS-CoV.

Yersiniosis is the third most commonly reported gastrointestinal infection in the EU/EEA after campylobacteriosis and salmonellosis.

Shigellosis is a relatively uncommon disease in the EU/EEA, but remains of concern in some countries and for some population groups. For 2020, 29 EU/EEA countries reported 1 806 confirmed shigellosis cases.

In 2019, 176 confirmed cases of congenital toxoplasmosis were reported in the EU/EEA, with Franceaccounting for 76% of all confirmed cases due to its active screening of pregnant women.